Author
1. Iyengar Arpana
2. Jha Vivekanand
3. Modi Gopesh K
ISBN
9789352705115
DOI
10.5005/jp/books/18440_130
Edition
1/e
Publishing Year
2018
Pages
1
Author Affiliations
1.
St John’s Medical College Hospital, Bengaluru, Karnataka, India,
St John’s Medical College, Bengaluru, Karnataka, India,
Children’s Kidney Care Centre, St John’s National Academy of Health Sciences, Bengaluru, Karnataka, India,
St. John's National Academy of Health Sciences, Bangalore, Karnataka, India,
St John’s National Academy of Health Sciences, Bengaluru, Karnataka, India,
St. John’s Medical College and Hospital, Bengaluru, Karnataka, India
2.
Postgraduate Institute of Medical Education and Research, Chandigarh, India,
George Institute for Global Health, New Delhi, India; Chair of Global Kidney Health, Imperial College, London, UK; Aykai Hospital, Ludhiana, Punjab, India,
George Institute for Global Health, New Delhi, India; Global Kidney Health, Imperial College, London, UK; Aykai Hospital, Ludhiana, Punjab, India,
The George Institute for Global Health, Fortis Escorts Hospital, New Delhi, India,
The George Institute for Global Health; Fortis Escorts Hospital, New Delhi, India,
George Institute for Global Health, India, New Delhi, India; Global Kidney Health Imperial College, London, United Kingdom,
The George Institute for Global Health, India; James Martin Fellow, University of Oxford; University of New South Wales, Sydney, Australia; International Society of Nephrology,
Coordinator of Stem Cell Research Facility, P.G.I.M.E.R., Chandigarh, India,
Postgraduate Institute of Medical, Education and Research, Chandigarh
3.
Noble Samarpan Kidney Centre, Bhopal, Madhya Pradesh, India,
Noble-Samarpan Kidney Centre, Bhopal, Madhya Pradesh, India
Chapter keywords
Empagliflozin,
urinary albumin-to-creatinine ratio,
type 2 diabetes,
cardiovascular disease,
exploratory analysis,
randomised controlled trial,
placebo-controlled trial,
sodium-glucose co-transporter-2,
urinary albumin-to-creatinine ratio,
UACR,
macro albuminuria